134 results
Page 3 of 7
8-K
EX-99.1
2c2uwnhhpctsccp9
11 Aug 22
Motus GI Reports Second Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
v5e21h 8u
11 Aug 22
Other Events
8:05am
8-K
EX-99.1
jhqan49z
24 May 22
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System
4:10pm
8-K
EX-99.1
hrn9ki
12 May 22
Motus GI Reports First Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
44pjx abroi
21 Apr 22
Regulation FD Disclosure
8:05am
8-K
EX-99.1
yu9aaa6zg
29 Mar 22
Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm
8-K
EX-99.1
blmo4qjr5ep7pax8e5ey
24 Feb 22
Motus GI Granted 180-Day Extension to Meet NASDAQ Minimum Bid Price Requirement
8:10am
8-K
EX-99.1
4cmpx8
14 Feb 22
Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System
6:40am
8-K
EX-99.1
1g10b8746c5uvont6
16 Dec 21
Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features
8:40am
8-K
EX-99.1
a3rw1a
12 Nov 21
Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update
8:07am
8-K
EX-99.1
oaaxnoq99h4n4de5vqb
26 Oct 21
Motus GI Announces Presentation of Results from Independent Study of Pure-Vu System in IBP Patients at the 2021 ACG Annual Scientific Meeting
8:12am
8-K
EX-99.1
09o1chj2
8 Sep 21
Motus GI Announces Enrollment of Patients at Second Site in the European Union
8:16am
8-K
EX-99.1
sp1kclxppwpt5
12 Aug 21
Motus GI Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-99.1
3mx8gu2tap43aq
21 Jul 21
Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy
8:06am